Skip to main content
SpringerLink
Log in

Higher-value diabetes interventions save costs, gain QALYs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2012 US dollars

Reference

  • Zhong Y, et al. Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence. Value in Health 18: 308-314, No. 2, 1 Mar 2015

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Higher-value diabetes interventions save costs, gain QALYs. PharmacoEcon Outcomes News 725, 13 (2015). https://doi.org/10.1007/s40274-015-2027-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2027-8

Search

Navigation